WARATAH PHARMACEUTICALS, INC.
Patent Owner
Stats
- 1 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 23, 2014 most recent publication
Details
- 1 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 388 Total Citation Count
- Dec 14, 1992 Earliest Filing
- 34 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0155,480 Scyllo-Inositol Derivatives and Their Use in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation of Amyloid Formation, Deposition, Accumulation for PersistenceAbandonedFeb 05, 14Jun 05, 14[C07C]
2014/0135,403 USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF OCULAR DISEASESAbandonedJan 16, 14May 15, 14[A61K]
2011/0034,379 Gastrin Compositions And Formulations, And Methods Of Use And PreparationAbandonedJul 26, 10Feb 10, 11[A61K, A61P, C07K]
2011/0028,719 SCREENING METHODS FOR AMYLOID BETA MODULATORSAbandonedMay 18, 07Feb 03, 11[C07D, C40B]
2010/0292,157 Combination Treatments for Alzheimer's Disease and Similar DiseasesAbandonedNov 22, 07Nov 18, 10[A61K, C07H, C07D, C07C, A61P, C07K]
7803766 Gastrin compositions and formulations, and methods of use and preparationExpiredJan 31, 07Sep 28, 10[A61K, C07K]
2010/0173,960 The Combination of a Cyclohexanehexol and a NSAID for the Treatment of Neurodegenerative DiseasesAbandonedSep 20, 07Jul 08, 10[A61K, A61P]
2010/0168,250 USE OF CYCLOHEXANEHEXOL DERIVATIVES IN THE TREATMENT OF OCULAR DISEASEAbandonedApr 11, 08Jul 01, 10[A61K, C07C, A61P]
2010/0144,613 Combined use of DPP-IV Inhibitors and Gastrin CompoundsAbandonedOct 06, 06Jun 10, 10[A61K, A61P]
2010/0113,613 CYCLOHEXANE POLYALCOHOL FORMULATION FOR TREATMENT OF DISORDERS OF PROTEIN AGGREGATIONAbandonedMar 09, 07May 06, 10[A61K, C07C, A61P]
2010/0105,631 Inositol Compounds and Uses of Same in the Treatment of Diseases Characterized by Abnormal Protein Folding or Aggregation or Amyloid Formation, Desposition, Accumulation or PersistenceAbandonedNov 11, 09Apr 29, 10[A61K, A61P]
2010/0093,648 TREATMENT OF MACULAR DEGENERATION-RELATED DISORDERSAbandonedOct 09, 09Apr 15, 10[A61K, A61P]
2009/0202,494 Combined use of glp-1 agonists and gastrin for regulating blood glucose levelsAbandonedJan 28, 05Aug 13, 09[A61K]
7560425 Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetesExpiredJun 09, 03Jul 14, 09[A61K, A01N]
2009/0170,957 SCYLLO-INOSITOL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY ABNORMAL PROTEIN FOLDING OR AGGREGATION OR AMYLOID FORMATION, DEPOSITION, ACCUMULATION OR PERSISTENCEAbandonedOct 13, 06Jul 02, 09[A61K, A61P]
2009/0054,314 Combined use of DPP-IV inhibitors and gastrin compoundsAbandonedOct 06, 06Feb 26, 09[A61K, A61P]
7476388 Composition comprising a gastrin/CCK receptor ligand and an EGF receptor ligandExpiredNov 14, 05Jan 13, 09[A61K, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.